home / stock / dmttf / dmttf news

DMTTF News and Press, Small Pharma From 11/11/22

Stock Information
Company Name: Small Pharma
Stock Symbol: DMTTF
Market: OTC
Website: smallpharma.com
Menu
DMTTF DMTTF Quote DMTTF Short DMTTF News DMTTF Articles DMTTF Message Board
Get DMTTF Alerts

News, Short Squeeze, Breakout and More Instantly...
DMTTF - Small Pharma to Participate in November Investor and Healthcare Conferences

LONDON, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announ...
DMTTF - Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028

SPL028 is the Company’s injectable deuterated DMT candidate with multi-layered IP protection The Phase I study aims to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of IM and IV administration of SPL028 LONDON, Oct. 31, 2022 (GLO...

DMTTF - Second United States Patent Granted for Small Pharma's Psychedelics Portfolio

Brings total to twelve granted patents across the Company’s full portfolio LONDON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused o...

DMTTF - Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Last patient dosed in Phase IIa trial for lead product candidate, SPL026 with supportive therapy for the treatment of Major Depressive Disorder Completion of 12-week follow up anticipated by year end with data shortly thereafter SSRI drug interaction study init...
DMTTF - Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial in Patients With Major Depressive Disorder

LONDON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces tha...

DMTTF - Small Pharma enters into automatic share purchase plan

Small Pharma ( OTCQB:DMTTF ) on Tuesday said it had entered into a share purchase plan with Eight Capital as broker under its previously announced normal course issuer bid. The automatic share purchase plan was expected to be implemented effective as of Sept. 13, DMTTF said in a s...

DMTTF - Small Pharma Enters Into Automatic Share Purchase Plan

LONDON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announced tha...
DMTTF - Small Pharma to Participate in Upcoming September Investor Conferences

LONDON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that Geor...

DMTTF - Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

LONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that...

DMTTF - Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

LONDON, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that...
Previous 10 Next 10